US SEC Filings Daily Market Digest — August 26, 2026

26-08-2026

Check-Cap Ltd completed its merger with MBody AI Corp on August 26, 2026, with MBody AI surviving as a wholly-owned subsidiary. Former MBody AI shareholders received approximately 12,379,581 ordinary shares (about 90% of the company) in a stock-only deal, and the combined entity now trades under the symbol 'MBAI' on Nasdaq. The merger triggered a change of control, and the company also terminated its prior business combination agreement with Apollo Technology Capital Corporation, exchanging $16.3 million in loans for a 7.5% equity stake in Apollo.

• · The merger was completed under a Merger Agreement dated September 12, 2025.
• · Each share of MBody AI common stock was converted into 0.07971678051816 ordinary shares of Check-Cap (par value NIS 48.00 per share).
• · No cash consideration was paid to MBody AI shareholders.
• · The company submitted an initial listing application to Nasdaq, approved on August 21, 2026.
• · The Business Combination Agreement with Apollo (dated March 25, 2024) was terminated upon closing of the Merger.
• · The Apollo Loans were cancelled for no further consideration.
• · John Fowler previously raised over C$250 million in capital and led Supreme Cannabis to be acquired for ~US$430 million.
• · Tim Hayden has over 20 years of experience and previously served at Agrify Corporation and Vivo Cannabis Inc.
• · The Board now consists of seven members, with four independent directors (Ghaleb El Masri, Anurag Sharma, Kai Sorensen, Scott Walters).
• · Audit Committee: Kai Sorensen, Ghaleb El Masri, Scott Walters; Compensation Committee: Anurag Sharma, Ghaleb El Masri, Scott Walters; Nominating Committee: Anurag Sharma, Kai Sorensen, Scott Walters.

26-08-2026

Boston Scientific disclosed a cybersecurity incident on August 25, 2026, that has caused global operational disruptions, including the ability to process and ship customer orders. The company has activated incident response protocols with third-party experts, but the full scope, nature, and financial impact are not yet known, and no materiality determination has been made.

• · The incident was identified on August 25, 2026.
• · The company has not yet determined whether the incident is reasonably likely to have a material impact.
• · The timeline for full restoration of affected systems is not yet known.
• · Potential risks include unauthorized data release, litigation, reputational harm, and regulatory scrutiny.

26-08-2026

TORM plc reported its interim results for Q2 and H1 2026, showing a decline in revenue and profit compared to the prior year periods. Revenue for H1 2026 was $1,500M, down from $1,700M in H1 2025, a decrease of 11.8%. Net profit for H1 2026 was $300M, compared to $400M in H1 2025, a decline of 25.0%. The Tanker segment experienced lower freight rates, while the Marine Engineering segment remained flat.

• · The Tanker segment experienced lower freight rates in H1 2026 compared to H1 2025.
• · The Marine Engineering segment remained flat period-over-period.
• · The company declared a dividend distribution on August 26, 2026.
• · TORM has secondhand vessel commitments and committed scrubber installations and other minor investments.

26-08-2026

Lanvin Group Holdings Ltd filed its semi-annual report on Form 6-K for the six months ended June 30, 2026. The filing incorporates the report by reference into several registration statements. No specific financial figures are provided in the cover filing itself.

• · The semi-annual report is incorporated by reference into registration statements on Form F-3 (No. 333-276476), post-effective amendment No. 5 to Form F-1 on Form F-3 (No. 333-269150), and registration statement amendment No. 1 on Form F-3 (No. 333-280891).

26-08-2026

Addex Therapeutics Ltd filed a Form 6-K with the SEC on August 26, 2026, attaching a press release of the same date. The filing incorporates the press release by reference into its registration statements. The company cautions that its business faces significant risks, as detailed in its Annual Report on Form 20-F for the year ended December 31, 2025.

• · The press release is dated August 26, 2026.
• · The filing incorporates the press release by reference into registration statements on Form F-3 (No. 333-291644) and Form S-8 (Nos. 333-255124 and 333-272515).
• · The company's Annual Report on Form 20-F for the year ended December 31, 2025 was filed on May 15, 2026.

26-08-2026

Western Digital Corp entered into privately negotiated exchange agreements with holders of its 3.00% Convertible Senior Notes due 2028 to exchange approximately $191.0 million aggregate principal amount of notes for $192.7 million in cash and shares of common stock. The exchange transactions are expected to close on or after September 2, 2026, and the issuance of exchange shares will rely on a Section 4(a)(2) exemption from registration. The filing does not disclose any negative or flat metrics, as it is a discrete capital restructuring event.

• · The exchange agreements were entered into on August 26, 2026.
• · The exchange shares are issued based on the volume-weighted average price of WDC common stock on August 26, 2026.
• · The exchange transactions are expected to close on or after September 2, 2026, subject to customary closing conditions.
• · The issuance of exchange shares is exempt from registration under Section 4(a)(2) of the Securities Act.

26-08-2026

Artificial Intelligence Technology Solutions Inc. (AITX) filed a Form 8-K on August 26, 2026, to furnish a press release announcing an upcoming Q&A session titled 'AITX Invites Viewers Inside the PURSUON Strategy.' The filing is under Regulation FD (Item 7.01) and includes no financial results or material operational changes. The disclosure is informational and not deemed filed under the Exchange Act.

• · Press release titled 'AITX Invites Viewers Inside the PURSUON Strategy in Upcoming Q&A Session' issued on August 26, 2026.
• · Exhibit 99.1 contains the press release; it is furnished, not filed.
• · Filing is purely a Regulation FD disclosure; no financial statements or material events reported.

26-08-2026

Woodside Energy Group Ltd filed a Form 6-K with the SEC on August 26, 2026, including the transcript of its Half-Year 2026 results briefing. The filing serves as a routine disclosure for a foreign private issuer and does not contain specific financial figures or performance metrics.

• · The filing is a report of a foreign private issuer under Rules 13a-16 and 15d-16 of the Securities Exchange Act of 1934.
• · The attached exhibit is the transcript of the Half-Year 2026 Results Briefing, which likely contains detailed financial results.
• · The filing date is August 26, 2026.

26-08-2026

Charter Communications completed the acquisition of Cox Communications' commercial fiber and managed IT/cloud services businesses, with Cox Enterprises contributing the residential cable business to Charter. In connection with the closing, multiple supplemental indentures were executed to add Cox entities as guarantors and grant security interests, aligning the collateral and obligors across the combined capital structure on a pari passu basis. No financial figures or period-over-period comparisons are provided in this filing.

• · The Transaction Agreement was dated May 16, 2025, and the transaction closed on August 19, 2026.
• · Supplemental indentures were executed on August 24, 2026, for the CCO Indenture (Thirtieth), Cox Indenture (Twenty-Third), TWC Indenture (Eleventh), and TWCE Indenture (Twentieth).
• · The Charter Credit Agreement has been amended multiple times, most recently by Amendment No. 7 dated May 6, 2026.

26-08-2026

Ceragon Networks announced management will participate in the 10th Annual Lake Street Best Ideas Growth Conference on September 10, 2026, in New York City, where they will hold one-on-one meetings with investors. The filing is a routine Form 6-K disclosure of an investor conference appearance and contains no financial results, material business developments, or period-over-period comparisons.

26-08-2026

UP Fintech Holding Limited (TIGR) reported unaudited financial results for Q2 2026, ended June 30, 2026. The filing is a Form 6-K furnished with a press release detailing the company's quarterly performance. No specific financial figures or comparisons are provided in the filing body itself, only the announcement of the results.

• · The filing is a Form 6-K for the month of August 2026.
• · The company is a foreign private issuer with Commission File Number 001-38833.
• · The principal executive office is located at 1 Raffles Place, #35-61 One Raffles Place, Singapore (048616).
• · The press release is attached as Exhibit 99.1.

26-08-2026

DSC Holdings Ltd. filed a Form 6-K with the SEC on August 26, 2026, reporting its unaudited financial results for the second quarter of 2026. The filing was signed by Chief Financial Officer and Director Qin Zou. No specific financial figures or performance metrics were disclosed in the filing text itself, only the announcement of the results.

• · Filing is a Form 6-K (Report of Foreign Private Issuer) for the month of August 2026
• · Commission File Number: 333-296228
• · Principal executive office address: No. 2 Wangjiang North Road, Room 148, Zhongshan Community, Baiyun Street, Dongyang, Jinhua City, Zhejiang Province, People's Republic of China
• · The company files annual reports under Form 20-F
• · Exhibit 99.1 contains the full unaudited financial results for Q2 2026

26-08-2026

News Corp filed an 8-K on August 26, 2026, regarding its $1 billion stock repurchase program. The company disclosed that it provides daily buyback transaction information to the Australian Securities Exchange and attached the relevant ASX disclosures as exhibits. The filing updates shareholders on the ongoing repurchase authorization, noting management's forward-looking intentions to buy back Class A and Class B common stock from time to time.

• · The repurchase program is authorized for up to $1 billion aggregate of Class A and Class B common stock.
• · Daily disclosure of transactions is provided to the ASX as required by ASX rules.
• · The company explicitly disclaims any obligation to update forward-looking statements except as required by law.
• · The filing date is August 26, 2026, and the report date is August 25, 2026.

26-08-2026

Bleichroeder Acquisition Corp. III (SPAC) announced a business combination with Ursa Major, a defense propulsion company, to take it public via Inflection Point Mach 10 (NASDAQ: IPXX). The transaction is expected to close in Q1 2027. Ursa Major reported strong revenue growth from $18.5M in 2024 to $45M in 2025, with a 2026 target of $100M, but the company remains pre-profit and faces execution risks in scaling production from 8 to 500 Havoc missiles per year.

• · Ursa Major has over 11 years of propulsion heritage and achieved its first hypersonic flight in 2024.
• · The company has a near-term pipeline of $2.8B in opportunities.
• · Current Havoc production is 8 units per year; with capital infusion, target is 500 units per year.
• · Ursa Major owns nearly 500 acres across 6 sites for production expansion.
• · The company plans to produce over 1 million pounds of energetics per year at its new facility.
• · Key customers include the US Navy, US Air Force, BAE Systems, and RTX.
• · The transaction is expected to close in Q1 2027.

26-08-2026

Non-Invasive Monitoring Systems Inc. (NIMU) filed an S-4/A registration statement in connection with its proposed merger with Gravitics Inc. The filing provides unaudited financial statements for both entities, including Gravitics' results for the six months ended June 30, 2026. Gravitics reported revenue of $1.2M for H1 2026, up from $0.5M in H1 2025, but recorded a net loss of $5.0M, widening from a $3.2M loss in the prior-year period. The merger is expected to close following shareholder and regulatory approvals.

• · The filing is an amendment to the registration statement on Form S-4 originally filed in connection with the merger.
• · Gravitics is a space technology company; the merger would combine NIMU's shell corporate structure with Gravitics' operating business.
• · The filing includes audited financial statements for Gravitics for the fiscal year ended December 31, 2025, and unaudited interim statements for the six months ended June 30, 2026.
• · NIMU itself has minimal operations and is classified as a shell company.

26-08-2026

Evernorth Holdings Inc. filed an S-4/A registration statement with the SEC on August 25, 2026, amending its earlier filing related to a business combination with a SPAC. The filing includes numerous exhibits such as employment agreements with key executives (CEO Asheesh Birla, CFO Matthew Frymier, and others), intercompany facility agreements with Ripple Labs Inc. and Pathfinder Digital Assets LLC, and custodial services agreements with BitGo Bank. The document also contains undertakings and signatures from the company's officers, indicating progress toward the SPAC merger.

• · The filing is an amendment (S-4/A) to a registration statement originally filed on October 20, 2025.
• · Employment agreements were signed with Asheesh Birla (June 24, 2026), Matthew Frymier (May 26, 2026), Jessica Jonas (June 8, 2026), Sagar Shah (June 6, 2026), and Meg Nakamura (June 8, 2026).
• · Intercompany facility agreements exist between Ripple Labs Inc. and Pathfinder Digital Assets LLC (August 1, 2025) and between Ripple Labs Inc. and Evernorth Holdings Inc. (August 1, 2025), with amendments dated February 11, 2026.
• · Custodial services agreements were signed with BitGo Bank on October 9, 2025 (Evernorth) and October 22, 2025 (Pathfinder Digital Assets LLC).
• · The registration statement includes a filing fee table and various consents from legal and financial advisors.

26-08-2026

Caesars Entertainment, Inc. is soliciting stockholder approval for a merger proposal and an advisory 'golden parachute' compensation proposal. The Board recommends voting 'FOR' both proposals. The merger requires approval from a majority of outstanding shares, and failure to vote or abstentions effectively count as 'AGAINST'.

• · The merger requires the affirmative vote of a majority of outstanding shares of Company Common Stock.
• · Abstentions and failures to vote have the same effect as voting 'AGAINST' the merger proposal.
• · The advisory 'say on golden parachute' proposal is non-binding and required under the Dodd-Frank Act.
• · The Company has engaged Innisfree M&A Incorporated for proxy solicitation at a fee of up to approximately $30,000 per month.
• · The Board recommends voting 'FOR' both Proposal 1 (Merger) and Proposal 2 (Advisory Merger-Related Compensation).

26-08-2026

Nuwellis, Inc. posted an updated corporate presentation to its investor relations website on August 25, 2026, which will be used in investor communications and conferences. The filing is a routine Regulation FD disclosure and contains forward-looking statements. No specific financial results or material business developments were disclosed in the report itself.

26-08-2026

American Express Receivables Financing Corp III LLC filed an 8-K on August 26, 2026, disclosing updated loss, delinquency, and revenue experience for the American Express Credit Account Master Trust portfolio as of May 31, 2026. The trust's net charge-off rate improved to 1.23% (annualized) for the five months ended May 2026 from 1.33% in FY2025, while total delinquencies as a percentage of average receivables declined to 0.73% from 0.79%. However, the average number of accounts outstanding continued to shrink, falling to 12.3 million from 13.3 million in FY2025, reflecting a sustained decline in the trust's account base.

• · Additional accounts were most recently designated for the Trust Portfolio on October 1, 2018.
• · Average net loss per account experiencing a loss improved to $3.64 for the five months ended May 31, 2026, from $3.88 in FY2025.
• · Total recoveries as a percentage of average principal receivables outstanding increased to 0.74% (annualized) for the five months ended May 31, 2026, from 0.69% in FY2025.
• · The trust's average receivables outstanding (including finance charge and fee receivables) was $26.3 billion for the five months ended May 31, 2026, down from $26.7 billion in FY2025.
• · The number of accounts experiencing a loss for the five months ended May 31, 2026 was 35,107, compared to 87,268 for all of FY2025.

26-08-2026

On August 20, 2026, Thunder Mountain Gold, Inc. closed a private placement of 8,090,451 units at US$0.70 per unit, raising gross proceeds of US$5,663,316 to advance the South Mountain Project. The company also issued 94,089 finder warrants to Canadian brokers and paid US$66,563 in finder's fees. The closing is subject to TSX Venture Exchange final approval.

• · Each unit consists of one common share and one-half of one common share purchase warrant.
• · Each full warrant allows purchase of one additional common share at US$1.00 (CAD$1.42) for 24 months.
• · Finder warrants are non-transferable and also have a 24-month term with an exercise price of US$1.00 (CAD$1.42) per share.
• · Securities are restricted under the Securities Act and subject to a four-month hold period in Canada.
• · The offering was conducted outside the U.S. under Regulation S.

26-08-2026

Lightbridge Corporation has been selected to participate in the U.S. Department of Energy's Nuclear Energy Launch Pad Program, administered by the National Reactor Innovation Center at Idaho National Laboratory. This selection, announced on August 24, 2026, positions the company to potentially advance its nuclear fuel technology through a DOE initiative. No financial terms or specific milestones were disclosed in the filing.

• · The selection was announced via an INL press release on August 24, 2026.
• · The program is administered by the National Reactor Innovation Center at INL.
• · The filing does not disclose any financial terms, funding amounts, or specific project milestones.

26-08-2026

Generate Biomedicines disclosed that draft copies of three posters accepted for the European Respiratory Society (ERS) Congress 2026 were inadvertently made public early due to an embargo error. The posters present clinical trial results for GB-0895, a next-generation anti-TSLP monoclonal antibody, in asthma and COPD, including data from Phase 3 SOLAIRIA studies and a COPD pharmacodynamics study. The company filed the final posters as an exhibit to comply with Regulation FD.

• · The posters were inadvertently made available via the ERS website before the embargo expired at 6:01 p.m. ET on September 7, 2026.
• · The ERS Congress 2026 is scheduled for September 5-9, 2026.
• · GB-0895 is described as a next-generation, long-acting anti-TSLP antibody with potential for dosing every six months in asthma.
• · One poster covers pharmacologic activity in adults with COPD.

26-08-2026

Generation Income Properties, Inc. completed two property sale transactions in August 2026, generating proceeds used to pay down senior mortgage debt and reduce its preferred equity redemption obligation to Loci Capital. The dispositions included a Fresenius property in Chicago (closed Aug 21) and a six-property Dollar General portfolio (closed Aug 24). As of Aug 25, 2026, the company had 3,038,140 common shares outstanding.

• · The Fresenius property sale closed on August 21, 2026.
• · The Dollar General portfolio (six properties) sale closed on August 24, 2026.
• · Proceeds were applied to senior mortgage debt payoffs and to reduce the preferred equity redemption obligation to Loci Capital.
• · The company is an emerging growth company and has not elected to use the extended transition period for complying with new or revised financial accounting standards.

26-08-2026

Key Tronic Corp (KTCC) disclosed the FY2027 incentive compensation plan and granted RSU awards to its executive officers on August 20, 2026. CEO Brett R. Larsen can earn up to 150% of base salary under the ICP, while EVPs Anthony G. Voorhees and Philip S. Hochberg can earn up to 105%. Additionally, a new long-term incentive plan for FY2027-2029 was established, with target cash awards of $400,000 for Larsen, $190,000 for Voorhees, and $150,000 for Hochberg if performance targets are met.

• · The FY2027 ICP has three performance levels: entry, expected value, and overachievement; payments are a percentage of base salary.
• · RSU awards vest over three years in equal annual installments; 40-60% of CEO RSUs and 50% of EVP RSUs are performance-based tied to annual EBITDA threshold.
• · Non-employee director RSUs (10,724 each) vest on the first anniversary of grant.
• · FY2027-2029 LTI performance measures combine sales growth compared to industry and return on invested capital; actual payments can range from $0 to 150% above target.
• · No cash awards under LTI plan if performance does not exceed minimum targets.

26-08-2026

Donaldson Company reported record fourth quarter and full-year fiscal 2026 sales and earnings. Q4 sales rose 8.0% to $1,058.8 million and GAAP EPS increased 13.4% to $1.10, driven by strong organic volume and the Facet acquisition. However, Industrial Filtration Solutions sales declined 2.0% in Q4 and organic Aerospace & Defense sales fell 2.8% due to supply chain constraints, while full-year On-Road sales decreased 6.6%.

• · Q4 fiscal 2026 GAAP net earnings were $129.3 million, up 13.1% from $114.3 million in Q4 fiscal 2025.
• · Full-year fiscal 2026 GAAP net earnings were $453.8 million, up 23.7% from $367.0 million in fiscal 2025.
• · Q4 fiscal 2026 adjusted EPS was $1.15, up 11.7% from $1.03 in Q4 fiscal 2025.
• · Full-year fiscal 2026 adjusted EPS was $3.98, up 8.2% from $3.68 in fiscal 2025.
• · Q4 fiscal 2026 gross margin improved 180 bps to 36.3% from 34.5% in Q4 fiscal 2025.
• · Q4 fiscal 2026 operating margin improved 120 bps to 16.7% from 15.5% in Q4 fiscal 2025.
• · Q4 fiscal 2026 adjusted operating margin was 17.5%, up 110 bps from 16.4% in Q4 fiscal 2025.
• · Q4 fiscal 2026 interest expense more than doubled to $14.7 million from $7.1 million in Q4 fiscal 2025 due to Facet-related debt.
• · Full-year fiscal 2026 interest expense was $36.0 million, up 48.8% from $24.2 million in fiscal 2025.
• · Q4 fiscal 2026 effective tax rate was 22.5%, down from 23.6% in Q4 fiscal 2025.
• · Full-year fiscal 2026 dividends paid were $141.2 million, and share repurchases were $108.5 million (1.2% of shares outstanding).
• · Fiscal 2027 guidance: sales growth 5.5%-9.5%, EPS $4.22-$4.38 (including $0.12 Facet dilution), operating margin 16.6%-17.2%, interest expense $55M-$60M, effective tax rate 23.5%-25.5%, capex $70M-$90M, free cash flow conversion 95%-105%, and share repurchases of ~1% of shares outstanding.
• · Fiscal 2027 segment guidance: Mobile Solutions sales +2%-6%, Industrial Solutions sales mid-teens growth (IFS mid-single digits, Aerospace & Defense >50% including Facet), Life Sciences sales +7%-11%.
• · Organic Aerospace & Defense sales declined 2.8% in Q4 fiscal 2026 due to supply chain constraints, but are forecast to grow mid-teens organically in fiscal 2027.
• · Industrial Filtration Solutions sales declined 2.0% in Q4 fiscal 2026 due to weaker new equipment sales in dust collection.
• · Full-year fiscal 2026 On-Road sales declined 6.6% despite Q4 growth of 8.7%.
• · Off-Road sales were roughly flat in Q4 fiscal 2026 (0.1% growth), with construction growth offset by weaker agriculture sales.

26-08-2026

Director Ferguson Brian was awarded 479 Common Stock. Ferguson Brian holds 869 shares after the transaction.

• · Director Ferguson Brian was awarded 479 Common Stock

26-08-2026

Director Lee Hon Sang sold 11,470 American depositary shares at $5.55 (~$63.7K).

• · Director Lee Hon Sang sold 11,470 American depositary shares at $5.55 (~$63.7K)

26-08-2026

Alibaba Group Holding Limited filed a Form 6-K with the SEC on August 26, 2026, disclosing a Next Day Disclosure Return submitted to the Hong Kong Stock Exchange regarding movements in its authorized issued shares or treasury shares. The filing is a routine regulatory compliance disclosure and contains no financial results or material business developments.

26-08-2026

Neo-Concept International Group Holdings Ltd (NCI) issued 140,000 Class B ordinary shares with super-voting rights (30 votes each) to its Chairman and CEO, Pengfei Jiang, for $350, giving him 64% voting power. The company also made changes to committee chairmanships and relied on Cayman Islands home country practice to bypass Nasdaq shareholder approval requirements. While the move aims to protect against hostile takeovers and ensure management stability, it significantly concentrates voting control in one individual, potentially diluting the influence of other shareholders.

• · The Class B shares are redeemable by the company at par value at any time at the Board's option and automatically convert to Class A shares upon transfer.
• · Prior to the issuance, all 2,364,282 outstanding shares were Class A, and the shareholder base was widely dispersed.
• · The company is not aware of any proposed or pending attempt to acquire control or accumulate a large block of shares.
• · The Audit Committee reviewed and approved the issuance as a related party transaction.
• · The company elected to follow Cayman Islands home country practice to bypass Nasdaq shareholder approval requirements under Listing Rules 5635(b) and 5635(d).
• · The contents of this Form 6-K are incorporated by reference into the company's Form F-3 and Form S-8 registration statements.

26-08-2026

BeOne Medicines Ltd. filed its 2026 Interim Report with the STAR Market, disclosing key differences between PRC GAAP and U.S. GAAP for the six months ended June 30, 2026. Total R&D expenses increased 14.6% year-over-year to $1,153,504 thousand, driven by higher internal R&D and collaboration costs. However, R&D spending on several key pipeline products declined, including BRUKINSA (-32.2%), TEVIMBRA (-8.1%), and BEQALZI (-21.3%), while emerging programs like tacabrutideg and BGB-43395 saw significant increases.

• · The filing highlights four key accounting differences between U.S. GAAP and PRC GAAP: share-based compensation (straight-line vs. accelerated method), income taxes in interim periods (single vs. jurisdictional effective tax rate), leasing (straight-line vs. front-loaded expense), and transfer of royalties from collaborative arrangements (liability vs. deferred revenue treatment).
• · R&D collaboration projects expense increased 75.3% YoY to $83,534 thousand, while other R&D projects decreased 12.1% to $98,283 thousand.
• · Emerging pipeline programs saw substantial R&D increases: BGB-B2033 (+528%), BG-C9074 (+243%), BGB-58067 (+501%), and BG-C477 (+372%).

26-08-2026

SharonAI Holdings Inc. entered into a First Supplemental Indenture on August 21, 2026, amending the Base Indenture governing its 6.00% Convertible Senior Notes due 2031. The amendment removes certain restrictive covenants, including limitations on incurring, maintaining, and repaying indebtedness and granting liens, providing the company with greater financial flexibility. No financial figures or period-over-period comparisons are provided in this filing.

• · The First Supplemental Indenture was entered into following receipt of requisite consents from noteholders.
• · The amendment removes restrictive covenants related to indebtedness and liens.
• · The Base Indenture was originally dated May 18, 2026.
• · The Notes carry a 6.00% coupon and mature on May 1, 2031.

26-08-2026

Kewaunee Scientific Corporation filed an 8-K announcing it has posted an investor presentation and related script to its website for its virtual Annual Meeting of Shareholders held on August 26, 2026. The presentation includes non-GAAP financial measures with reconciliations to GAAP. The filing is a routine disclosure of the meeting materials and contains no specific financial results or operational updates.

• · The Annual Meeting was conducted virtually at 11:00 a.m. Eastern time on August 26, 2026 via live webcast at www.virtualshareholdermeeting.com/KEQU2026.
• · A replay of the audio webcast will be available on the Company's website for approximately one year.
• · The presentation and script are furnished, not filed, under Item 7.01 of Form 8-K.

26-08-2026

President Denier Anthony Michael sold 53,848 Class A Ordinary Shares at $8.83 (~$476K). Denier Anthony Michael holds 2,332,295 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · President Denier Anthony Michael sold 53,848 Class A Ordinary Shares at $8.83 (~$476K)

26-08-2026

President & CEO Donaghey Christopher Wayne exercised/converted 100,000 Common Stock, par value $0.001 per share. Donaghey Christopher Wayne holds 173,742 shares after the transaction. Trades executed under a Rule 10b5-1 plan.

• · President & CEO Donaghey Christopher Wayne exercised/converted 100,000 Common Stock, par value $0.001 per share
• · President & CEO Donaghey Christopher Wayne had withheld for taxes 39,850 Common Stock, par value $0.001 per share
• · President & CEO Donaghey Christopher Wayne exercised/converted 100,000 Restricted Stock Units

26-08-2026

Baidu, Inc. filed a Form 6-K with the SEC on August 26, 2026, reporting the results of its Extraordinary General Meeting (EGM) of shareholders. The filing includes a press release and an announcement to the Hong Kong Stock Exchange regarding the EGM outcomes. No specific financial results or operational metrics were disclosed in this filing.

• · The filing is a Form 6-K for the month of August 2026.
• · Commission File Number: 000-51469.
• · The EGM results were announced via press release (Exhibit 99.1) and a Hong Kong Stock Exchange announcement (Exhibit 99.2).

26-08-2026

United Microelectronics Corporation (UMC) filed a Form 6-K with the SEC disclosing its monthly net revenue for July 2026. The filing includes the registrant's signature by CFO Chitung Liu and an exhibit referenced as '6K on 08/26/2026', which likely contains the detailed revenue figures. No negative or flat performance metrics are mentioned in the provided text.

26-08-2026

Biohaven Ltd. (BHVN) entered into a strategic global licensing and collaboration agreement with SK Biopharmaceuticals for its Kv7 ion channel platform and lead candidate opakalim (BHV-7000), a Phase 2/3 Kv7.2/7.3 activator for focal epilepsy. Biohaven will receive $400 million in near-term cash ($350 million at closing plus $50 million in 2027), with potential milestone payments up to $795 million and tiered U.S. royalties (mid-teens to low twenties) plus ex-U.S. royalties. The deal provides non-dilutive capital and extends Biohaven's runway, while SK Biopharmaceuticals assumes future development costs and certain Knopp obligations; however, Biohaven forgoes direct commercialization of opakalim and retains only royalty-based upside.

• · SK Biopharmaceuticals will assume responsibility for Kv7 program costs going forward, including up to $185 million payable to Knopp Biosciences upon U.S. and EU approval plus a mid-single digit worldwide royalty.
• · SK Biopharmaceuticals will also assume up to $60 million in additional obligations for milestones related to future Kv7 pipeline programs.
• · Opakalim has been studied in more than 1,200 participants across multiple clinical trials.
• · Biohaven is conducting two Phase 2/3 randomized, double-blind, placebo-controlled studies (NCT06132893 and NCT06309966) and an open-label extension study (NCT06443463).
• · SK Life Science has a neurology field force of over 150 professionals.
• · Closing is contingent on HSR antitrust review and other customary conditions.
• · J.P. Morgan Securities LLC served as exclusive financial advisor to Biohaven; Sullivan & Cromwell LLP as legal advisor.
• · Nomura Securities International, Inc. served as exclusive financial advisor to SK Biopharmaceuticals; Paul Hastings LLP as legal counsel.

26-08-2026

Noah Holdings Ltd filed a Form 6-K with the SEC on August 26, 2026, attaching its interim results announcement for the six months ended June 30, 2026, as disclosed on the Hong Kong Stock Exchange. The filing does not contain any specific financial figures or performance data, only the cover notice and incorporation of the HKEx announcement by reference.

26-08-2026

Perfect Corp. filed a Form 6-K with the SEC on August 26, 2026, announcing an extraordinary general meeting of shareholders. The press release regarding the convening of this meeting is attached as Exhibit 99.1. No additional financial or operational data was disclosed in this filing.

26-08-2026

Target Hospitality Corp. announced a new multi-year lease and services agreement to provide facility and hospitality services for a data center community in the Pecos region of West Texas. The community will accommodate approximately 1,100 individuals, with initial occupancy in August 2026 and full completion expected in September 2026, under a four-year contract. The company also issued a revised financial outlook alongside this agreement, though specific financial figures were not provided in the filing.

• · The contract has an anticipated four-year term.
• · The customer has termination rights with at least 60 days' notice if the prime contract is terminated, expires, suspended, or if the customer ceases performance.
• · In the event of early termination by the customer, Target Hospitality is entitled to an early termination fee under certain circumstances.
• · The company issued a revised financial outlook in conjunction with this announcement, but no specific figures were disclosed in the 8-K.

26-08-2026

Avalanche Treasury Corporation resolved its Nasdaq Capital Market continued-listing deficiency after Nasdaq determined on August 25, 2026 that the Company complied with Rule 5550(b)(2). Based on the Company’s June 30, 2026 Form 10-Q, stockholders’ equity was $83,766,235, exceeding the alternative $2.5 Million (M) equity requirement, and Nasdaq closed the matter; the Company therefore avoided delisting at this time.

• · The initial Nasdaq deficiency notification was received on August 6, 2026.
• · The relevant listing standard was Nasdaq Listing Rule 5550(b)(2).
• · The filing was signed on August 26, 2026 by Gerald Bartholomew Smith, Chief Executive Officer.
• · The registered security is Class A Common Stock, par value $0.01 per share, trading under the symbol AVAT.

26-08-2026

Chief Legal Officer Dahlquist Karl S. sold 9,370 Common Stock at $48.89 (~$458K). Dahlquist Karl S. holds 87,319 shares after the transaction.

• · Chief Legal Officer Dahlquist Karl S. sold 9,370 Common Stock at $48.89 (~$458K)